Biotech · Private company
Five Eleven Pharma, Inc.
Track this companyFree. Adds Five Eleven Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- PSMA-PET and SOC MRIPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- SOC MRIPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Ga-68 P16-093 PET/CT scanPhase 2 · Prostate Cancer RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- [18F]P16-129Phase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- [18F]P17-059Phase 1 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- [68Ga]P15-041Phase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- [68Ga]P16-093Phase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Initial Investigation of [18F]P17-059 in Parkinson's Disease Patients and Healthy VolunteersPHASE1 · COMPLETED · started Jul 15, 2022ClinicalTrials.gov NCT03903549 · fetched Nov 12, 2026
- PSMA-PET to Guide ProstatectomyPHASE2_PHASE3 · RECRUITING · started Oct 1, 2021ClinicalTrials.gov NCT05381103 · fetched Nov 12, 2026
- Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started May 10, 2018ClinicalTrials.gov NCT03444844 · fetched Nov 12, 2026
- Initial Investigation of [18F]P16-129 in Alzheimer's Disease Patients and Healthy VolunteersPHASE1 · COMPLETED · started Feb 21, 2018ClinicalTrials.gov NCT03902548 · fetched Nov 12, 2026
- Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal CancerPHASE1 · COMPLETED · started Jul 21, 2017ClinicalTrials.gov NCT03073395 · fetched Nov 12, 2026
- Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041EARLY_PHASE1 · COMPLETED · started Sep 20, 2016ClinicalTrials.gov NCT02826382 · fetched Nov 12, 2026